Skip to main content

Series B Biotechnology Companies

Explore 430 biotechnology startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
430
Total Funding
$1.3B
Avg Funding
$50.3M
Cities
20

Export 430 Series B Biotechnology Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Portland, United States
$95.0M
raised

Sparrow Pharmaceuticals is a clinical-stage biopharmaceutical company developing treatments for disorders of corticosteroid excess.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Wageningen, The Netherlands
$28.3M
raised

Revyve is a food-tech company that produces texturizing ingredients from yeast to replicate the function of eggs in various food categories.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Valencia, Spain
$40.6M
raised

AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Jersey City, United States
$17.0M
raised

Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Bloomington, United States
$26.6M
raised

Fasikl is a neuro-AI company that creates interfaces for the nervous system.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Gladwyne, United States
$11.0M
raised

Xanadu Bio is a nanoparticle delivery company focusing on the delivery of mRNA and other nucleic acids that uses PACE platform technology.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Boston, United States
$25.0M
raised

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom
$67.5M
raised

NRG Therapeutics is a drug discovery company focussed on therapeutic approaches that will restore mitochondrial function.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$60.0M
raised

Avenzo Therapeutics specializes in the development of oncology therapies for cancer treatment.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Mountain View, United States
$20.0M
raised

Boomerang Medical is a bioelectronic medical enterprise.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Ghent, Belgium
$64.1M
raised

MRM Health NV is a biopharmaceutical company focused on the discovery and development of therapeutics based on the human microbiome.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Natick, United States
$59.0M
raised

Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.

Sep 2025
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom
$44.0M
raised

Cyted uses artificial intelligence (AI) and digital pathology to improve the detection and diagnosis of diseases, including cancer.

Aug 2025
Series B

Founder Contacts

41,000+ verified contacts

Blue Bell, United States
$3.9M
raised

Seneca is a biotechnology company that focuses on developing novel oncolytic immunotherapeutics for the treatment of cancer.

Aug 2025
Series B

Founder Contacts

41,000+ verified contacts

Copenhagen, Denmark
$40.8M
raised

SNIPR Biome is a operator of a discovery stage biotech company intended to revolutionize the treatment of microbial diseases.

Aug 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$153.0M
raised

Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.

Aug 2025
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$132.0M
raised

ARTBIO is a clinical-stage radiopharmaceutical biotechnology business that is working to create a new class of alpha radioligand medicines.

Jul 2025
Series B

Founder Contacts

41,000+ verified contacts

Fishers, United States
$18.4M
raised

Microbiome Innovation for Animal Health

Jul 2025
Series B

Founder Contacts

41,000+ verified contacts

Hayward, United States
$31.0M
raised

Aqtual is a biotechnology diagnostics platform that provides healthcare solutions, novel technology, and biochemistry for chronic disease.

Jul 2025
Series B

Founder Contacts

41,000+ verified contacts

Saint-antoine, France
$38.9M
raised

BrainEver is a operator of a medical research agency intended to offer drugs for the treatment of neurodegenerative disorders.

Jul 2025
Series B

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 430 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Gent, Belgium
$11.8M
raised

Animab is a biotechnology company specializing in proprietary technology that supports livestock health.

Jul 2025
Series B

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$50.0M
raised

Terrana's innovative technology platform uses RNA-based plant health solutions to enable resilient agriculture for a world.

Jul 2025
Series B

Founder Contacts

41,000+ verified contacts

Norwich, United Kingdom
$18.0M
raised

Colorifix is the first company to use a biological process to produce, deposit and fix pigments onto textiles.

Jun 2025
Series B

Founder Contacts

41,000+ verified contacts

San Diego, United States
$66.0M
raised

Actio Biosciences is a research center that develops drugs for rare diseases.

Jun 2025
Series B

Founder Contacts

41,000+ verified contacts

Barcelona, Spain
$135.0M
raised

Splice Bio develops gene therapies using its Protein Splicing platform for genetic diseases.

Jun 2025
Series B

Founder Contacts

41,000+ verified contacts

Showing 101 to 125 of 430 companies

Ready to Connect with Series B Biotechnology Startups?

Get verified founder emails, funding details, and company data for 430 series b biotechnology companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked